Pacira BioSciences (NASDAQ:PCRX) reported its Q1 earnings results on Wednesday, May 4, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Pacira BioSciences missed estimated earnings by 22.89%, reporting an EPS of $0.64 versus an estimate of $0.83.
Revenue was up $38.96 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.07 which was followed by a 4.89% increase in the share price the next day.
Here's a look at Pacira BioSciences's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.90 | 0.65 | 0.69 | 0.63 |
| EPS Actual | 0.97 | 0.72 | 0.77 | 0.53 |
| Revenue Estimate | 155.74M | 130.38M | 128.01M | 119.28M |
| Revenue Actual | 159.19M | 127.72M | 135.59M | 119.03M |
To track all earnings releases for Pacira BioSciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
